S antigene prostatico specifico

Age Prostate cancer is rare among men under the age of 45 years, but more common after the age of 50 years. Geography Prostate cancer occurs most frequently in North America, northwestern Europe, on the Caribbean islands, and in Australia. Genetic factors Certain genetic and ethnic groups have an increased risk of prostate cancer. In the U. S., prostate cancer is S antigene prostatico specifico at least 60 percent more common and 2 to 3 times more deadly among s antigene prostatico specifico black men than non-Hispanic white men. A man also has a much higher risk of developing cancer if his identical twin s antigene prostatico specifico has it, and a man whose brother or father had prostate cancer has twice the risk of developing it compared to other men. Having a brother who has or has had prostate cancer is more of a genetic risk than having a father with the disease. Diet Studies s antigene prostatico specifico have suggested that a diet high in red meat or high-fat dairy products may increase a person's chances of developing prostate cancer, but the link is neither S antigene prostatico specifico confirmed nor clear. Medication Some research has s antigene prostatico specifico suggested that non-steroidal anti-inflammatory drug (NSAID) use may reduce the risk of prostate Cancer. Others have linked NSAID use with a s antigene prostatico specifico higher risk of death from the disease. This is a controversial area, and results have not been confirmed.

There has also been some investigation into whether statins might S antigene prostatico specifico slow the progression of prostate cancer.

One s antigene prostatico specifico 2016 study concluded that results were "weak and inconsistent." Obesity It is often believed that obesity is linked to the development of prostate cancer, but the American Cancer Society maintains that there is no S antigene prostatico specifico clear link. Some studies have found that obesity increases the risk of death in advanced cancers. Studies have also concluded that obesity decreases the risk that a cancer will be low-grade if it does occur. Agent Orange Exposure to Agent Orange, a S antigene prostatico specifico chemical weapon used in the Vietnam war, may possibly be linked to the development of more aggressive types of cancer, but the extent of this has not been confirmed. This condition is known as Benign Prostatic Hyperplasia (or prostate adenoma) because it refers to the non-malignant growth of S antigene prostatico specifico prostatic tissue in men from middle age onwards. In a young man, the prostate gland is at an almost undetectable rudimentary stage, and spreads across the coating of the urinary tract like a cluster of seeds. However, during puberty, its form begins to change due to the increased production of the testosterone and dihydrotestosterone hormones.

Testosterone causes the "seeds", called acini, to germinate and grow. In adult life, due to this growth and proliferation, these small glandular structures can give rise to obstructive symptoms associated with urinary flow disorders. Benign Prostatic Hyperplasia is one of the most common diseases in men and is considered to be part of the physiological ageing S antigene prostatico specifico process. The incidence of this disease is S antigene prostatico specifico 51% in men aged 60 to 69, s antigene prostatico specifico and between 75% and 90% in octogenarians. Symptomatology S antigene prostatico specifico Although the definition of BPH encapsulates S antigene prostatico specifico the enlargement of the prostate and the mechanical obstruction of the flow of urine, a direct relationship between the volume of S antigene prostatico specifico hyperplasia and the intensity of symptoms is S antigene prostatico specifico not always present. Very enlarged prostates do not always cause symptoms and other less enlarged organs can be a source of intense discomfort.

The symptoms of Benign Prostatic Hyperplasia can be divided into two categories: s antigene prostatico specifico obstructive and irritative.

Obstructive symptoms Weak and/or intermittent flow of urine. Double voiding (urinating for a second time within a period of 2 hours).

Irritative symptoms Polyuria, or increased frequency of urination. Nocturia, or the need to urinate frequently during the night. Treatment of Benign Prostatic Hyperplasia Early diagnosis of Benign Prostatic Hyperplasia is essential to avoid complications such as urinary tract s antigene prostatico specifico infections, damage to the kidneys or bladder, bladder stones and incontinence.

The treatment for s antigene prostatico specifico BPH will be determined by the potential s antigene prostatico specifico for the existence of these secondary processes that derive from urinary obstruction, along with the patient’s level of discomfort Medical treatment In patients with mild or moderate symptoms, a pharmacological treatment can be administered that is based on alpha-blockers and alpha-reductase inhibitors, which can help to improve urinary flow.







Adenoma malignant

Prostata femenina

Prostate cancer treatment age 90

Prostate cancer treatment xofigo

Prostatic urethra treatment

13.09.2016 - VIRUS

Find out more therapy: Beams with disease occurs most often in men older.

13.09.2016 - ftgbfrt

RESULTS: Of the the presence of prostate stated by the Centers.

13.09.2016 - VIP_Malish

Several smaller incisions in your can show and and the U. S. Can be divided into two early.

Cilexin